|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.83 EUR | +0.32% |
|
+2.30% | +2.22% |
| 05-18 | Bayer agrees to pay $133 million for PCB cleanup in two states | RE |
| 05-18 | U.S. FDA grants priority review to supplemental new drug application for Hyrnuo® (sevabertinib) | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 43.05B | |||||
| 896B | |||||
| 546B | |||||
| 372B | |||||
| 328B | |||||
| 283B |
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition